Global Respiratory Care Devices Market Set to Reach US$ 49.19 Billion by 2033 Amid Soaring Respiratory Disorders and Technological Innovation
The global respiratory care devices market is undergoing rapid transformation, fueled by rising incidences of chronic respiratory diseases, growing elderly populations, and increasing adoption of innovative respiratory technologies. According to recent industry estimates, the market is projected to grow from US$ 24.16 billion in 2024 to a staggering US$ 49.19 billion by 2033, expanding at a CAGR of 8.22% during the forecast period.
Respiratory Care Devices Market Overview Respiratory care devices play a crucial role in supporting patients suffering from compromised pulmonary function. These devices are vital in managing conditions like asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and obstructive sleep apnea. Respiratory care devices include:
- Ventilators: Provide mechanical breathing assistance for critically ill patients.
- Nebulizers: Convert liquid medication into mist for easy inhalation.
- Oxygen Concentrators: Supply purified oxygen for patients with low blood oxygen levels.
- CPAP Devices: Help maintain positive airway pressure in sleep apnea patients.
These technologies are essential in hospitals, clinics, and increasingly in home care settings, significantly enhancing patient outcomes and quality of life.
Key Market Drivers
1. Rising Burden of Respiratory Disorders The increasing prevalence of asthma, COPD, and sleep apnea continues to drive demand for respiratory care devices. According to the World Health Organization (WHO), chronic respiratory diseases (CRDs) are responsible for 4.1 million deaths annually. Major causes include air pollution, smoking, and occupational hazards, especially in urban and industrial areas. An aging global population—more vulnerable to declining lung function—further exacerbates the situation.
2. Technological Advancements and Smart Devices Innovative developments such as AI-integrated smart inhalers, wearable oxygen systems, and remote monitoring tools are revolutionizing patient care. Devices now offer wireless connectivity and real-time data sharing, enabling clinicians to optimize treatments. For example, IMVARIA Inc.'s FDA-approved Fibresolve diagnostic tool, launched in January 2024, uses AI to non-invasively detect lung fibrosis, streamlining diagnosis and treatment.
3. Increased Awareness and Government Initiatives Governments and NGOs worldwide are launching respiratory health awareness campaigns. These efforts promote early diagnosis and drive demand for advanced treatment solutions. In April 2024, Royal Philips began developing a new Sleep & Respiratory Care R&D center in India, reinforcing the global push for localized innovation and accessibility.
Regional Market Highlights
United States The U.S. leads North America’s respiratory care market due to high COPD and asthma prevalence, superior healthcare infrastructure, and strong innovation pipelines. The country benefits from the presence of global players and continued advancements in home-use technologies like non-invasive ventilators. In February 2023, React Health acquired Invacare’s Respiratory division, expanding its reach and product offerings.
Germany Germany boasts a robust respiratory care market, fueled by its advanced healthcare system and high COPD rates. With over 2.7 million COPD patients (NIHR, 2019), demand for ventilators and oxygen therapy devices is strong. Germany also remains a center for R&D, pushing innovations like high-flow nasal cannulas and portable respiratory support systems.
China Rapid industrialization and urban pollution are major contributors to respiratory illness in China. Combined with high smoking rates and an aging demographic, this has led to increased adoption of devices like CPAP machines and nebulizers. The government supports this growth with initiatives to strengthen healthcare infrastructure. In 2022, Bolivia selected China’s CANTA oxygen concentrators for their performance at high altitudes.
Brazil Brazil is Latin America’s respiratory care leader, grappling with widespread tuberculosis and COPD. Urban air pollution exacerbates demand for portable and non-invasive respiratory solutions. The 2022 update to Brazilian Good Manufacturing Practices by ANVISA is also expected to boost regulatory compliance and product innovation.
Saudi Arabia Saudi Arabia’s respiratory care market is driven by government investments aligned with Vision 2030. Rising respiratory conditions, especially among aging and obese populations, are increasing demand for advanced devices. In September 2024, EVA Pharma launched initiatives to provide affordable respiratory solutions, particularly for asthma and COPD.
South Africa As the dominant player in Africa’s respiratory market, South Africa faces rising cases of tuberculosis, asthma, and COPD. Urbanization and environmental degradation increase reliance on respiratory devices. Government partnerships with global medical firms aim to improve device accessibility across public health systems.
New Publish Blog :
Top Intraocular Lens Companies in 2025 – Market Leaders & Trends
Top 7 Global Electric Vehicle Companies in 2025
Top 9 Leading Respiratory Care Devices Companies in 2025
Company Developments
Medtronic
- Feb 2024: Announced merger of patient tracking and respiratory segments.
- 2020: Released the Puritan Bennett 980 ventilator with personalized ventilation algorithms.
Philips
- Jan 2024: Halted sales of U.S. respiratory products under DOJ consent decree.
- 2021: Launched Trilogy Evo ventilator for both acute and chronic use.
GE Healthcare
- 2020: Introduced the Carescape R860 ventilator with advanced tracking and ventilation modes.
Masimo Corporation
- Jan 2020: Acquired NantHealth's Connected Care business, enhancing noninvasive monitoring capabilities.
ResMed Inc.
- 2021: Rolled out AI-powered AirSense 11 CPAP machines.
- 2020: Released AirFit F30i, a compact full-face sleep apnea mask.
Getinge AB
- Jan 2023: Introduced the Servo-C ICU ventilator for pediatric and adult care.
Inogen Inc.
- Dec 2022: Rove 6 launched in Europe; offers 6 settings with an 8-year life span.
- 2023: FDA cleared the 4-setting Rove 4 in the U.S.
Product Segmentation
By Device Type:
- Therapeutic Devices
- Monitoring Devices
- Diagnostic Devices
- Consumables & Accessories
By Products:
- Respiratory Consumables
- Nebulizers
- Oxygen Concentrators
- Polysomnography Devices
- Pulse Oximeters
- Mechanical Ventilators
- Spirometers
- Others
By Application:
- Chronic Obstructive Pulmonary Disease (COPD)
- Obstructive Sleep Apnea
- Asthma
- Respiratory Distress Syndrome
- Cystic Fibrosis
Conclusion The global respiratory care devices market is at a pivotal growth juncture. As awareness, demand, and investment surge across developed and developing regions, the market will continue to evolve with technology at its core. From AI-based diagnostics to compact and wearable ventilators, the focus is shifting toward patient-centric and home-based care models, ensuring more personalized, effective, and accessible respiratory care worldwide.
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: mailto:rajat@renub.com
Comments
0 comment